[ad_1]
The first phase III clinical trials on Donepezil dementia in the world are increasing, according to the information that the results will be published on the 25th.
From 15:03 on December 20th, On the 25th, Aicure announces the results of the third phase of & quot; Donepezil Dementia Patch & # 39; at the International Conference of the Alzheimer's Association (AAIC2018) at the International Conference of the Alzheimer's Association
AAIC2018 will be held in Chicago, USA, from February 22 to 27, to share the latest research findings and the latest theories in the field of dementia.
Through unique technology, AICURE is the world's first donepezil
Currently, the FDA responds that it is possible to obtain only the first phase of the clinical trial.
Donepezil accounts for about 80% of the total dementia drug market.It is the most common drug in the world.
In the news, it is said that the rise in prices is due to the rise in the price of ice, which is considered an organic stock with pharmaceuticals, Naebec, Medifron, etc.
[ad_2]
Source link
